|
RBM26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.36189973029855E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.03450000022276E-07 |
| Normal-vs-Stage2 |
5.1832000003138E-07 |
| Normal-vs-Stage3 |
6.99400537484962E-11 |
| Normal-vs-Stage4 |
8.05980004958684E-09 |
| Stage1-vs-Stage2 |
1.459850E-01 |
| Stage1-vs-Stage3 |
1.139530E-02 |
| Stage1-vs-Stage4 |
2.128100E-02 |
| Stage2-vs-Stage3 |
7.076000E-01 |
| Stage2-vs-Stage4 |
7.217400E-01 |
| Stage3-vs-Stage4 |
9.841000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.3207005468181E-10 |
| Normal-vs-AfricanAmerican |
4.798700E-03 |
| Normal-vs-Asian |
9.82590000000449E-05 |
| Caucasian-vs-AfricanAmerican |
3.366200E-01 |
| Caucasian-vs-Asian |
3.883400E-01 |
| AfricanAmerican-vs-Asian |
7.812800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.37030436681607E-11 |
| Normal-vs-Female |
1.54910000382813E-08 |
| Male-vs-Female |
8.066400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.98909999996155E-06 |
| Normal-vs-Age(41-60Yrs) |
1.20230000399957E-08 |
| Normal-vs-Age(61-80Yrs) |
3.76439990290578E-11 |
| Normal-vs-Age(81-100Yrs) |
3.249400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.278810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.184400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.500000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.157390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.364200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.851000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.563500E-03 |
| Classical-VS-Follicular |
3.583800E-02 |
| Classical-VS-Other |
3.079000E-01 |
| Classical-VS-Normal |
7.7810999976613E-08 |
| Tall-VS-Follicular |
3.807000E-01 |
| Tall-VS-Other |
7.646200E-01 |
| Tall-VS-Normal |
5.73759995070589E-09 |
| Follicular-VS-Other |
8.779800E-01 |
| Follicular-VS-Normal |
1.19840000034621E-07 |
| Other-VS-Normal |
5.702800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.3583000280093E-09 |
| Normal-vs-N1 |
5.73299999695465E-08 |
| N0-vs-N1 |
4.519800E-01 |
|
|
